Bill S-201 explained in plain English
An Act respecting a national framework on sickle cell disease
Federal Parliament bill summary, status, timeline, sponsor, votes, and official sources.
At a glance
Official Parliament of Canada snapshot for 45th Parliament, 1st Session. MP vote breakdowns appear when the House of Commons publishes a recorded division export for that bill. Senate and House stage details include official debate/sitting links when LEGISinfo publishes them.
Our plain-language take, written for civic education.
Source: By PoliticalData.ca
Bill S-201 creates a national framework to improve care, research, and awareness for sickle cell disease in Canada.
Bill S-201 establishes a national framework to address sickle cell disease (SCD) in Canada. The bill outlines measures to improve access to care, support research, and enhance public awareness. Key provisions include creating a national SCD strategy, requiring provinces/territories to develop action plans, and establishing a national registry for SCD patients. The bill also mandates the Minister of Health to report on progress and allocate funding for research and treatment programs.
- Establishes a national sickle cell disease strategy
- Requires provinces/territories to create local action plans
- Mandates the creation of a national SCD patient registry
- Requires the Minister of Health to report on progress
- Allocates funding for research and treatment programs
- Provinces and territories
- Healthcare providers
- Sickle cell disease patients
- Researchers
- Federal government departments
- The bill does not specify exact funding amounts or timelines for implementation.
- The exact scope of the national registry and data collection requirements is not detailed in the text.
- The mechanisms for provincial/territorial collaboration are not fully outlined.
Establishes obligations for federal and provincial governments to address SCD.
Expands the Minister of Health's responsibilities to include SCD-related reporting and funding.
Generated using AI from official bill text. Not legal advice. It is written by PoliticalData.ca for civic education, automatically checked and spot-reviewed before publishing.
Official textParliamentary Process
Bill S-201 completed its Senate first reading on May 28, 2025, advancing it to second reading in the House of Commons.
Bill S-201, which proposes a national framework for sickle cell disease, completed its first reading in the Senate on May 28, 2025. This procedural step formally introduced the bill to the Senate. The bill is now at second reading in the House of Commons, with its latest major activity being debate on April 17, 2026. No legal changes were enacted during the Senate first reading, which only advances the bill through the legislative process.
The Senate debate covers the introduction of bills, questions about official languages appointments, trade disputes, and a reference to the Speech from the Throne.
The Senate debate transcript includes several key topics. First, there is a welcome to new senators, followed by the introduction of bills S-211 and S-212. A senator raises a question about the appointment of the Commissioner of Official Languages, which the government responds to by citing the 2023-2024 budget. Another senator questions the government's stance on interprovincial trade disputes, and the government acknowledges the complexity of such issues. Finally, a speech from the throne is referenced, with a note on land acknowledgment practices.
The Senate completed second reading of Bill S-201 on June 3, 2025, advancing it to committee, while the bill is now at second reading in the House of Commons.
This record documents the Senate's completion of second reading for Bill S-201, which proposes a national framework for sickle cell disease. The Senate completed this procedural stage on June 3, 2025 (Sitting 5), allowing the bill to advance to committee consideration. A sponsor's speech was delivered by Senator Marie-Françoise Mégie (Independent Senators Group) during the second reading. A response speech was given by Senator Salma Ataullahjan (Conservative) on June 12, 2025 (Sitting 10). The bill is now at second reading in the House of Commons, with a scheduled debate on April 17, 2026. Similar bills (S-280, C-221, C-605) have been introduced in previous parliaments but are not directly related to this specific stage. The official text is available at [link](https://www.parl.ca/legisinfo/en/bill/45-1/s-201).
The Senate debated proposals to limit the use of the 'notwithstanding' clause in the Constitution, focusing on Bill S-218 and related bills, with discussions on procedural safeguards, federal-provincial jurisdiction, and public awareness.
The Senate debate transcript details discussions around the 'notwithstanding' clause in the Constitution, specifically focusing on Bill S-218, which proposes procedural safeguards to limit its use. Key topics include: (1) Concerns about the clause's potential for abuse, with some senators advocating for stricter limits on its application by federal and provincial governments. (2) Reference to Bill C-21, which would require a five-year sunset clause for laws using the 'notwithstanding' clause. (3) Debate over whether the clause should be restricted to specific areas like human rights, with some arguing it should not apply to provincial laws. (4) Mention of the need for public awareness to ensure the clause's intended effect is maintained. The discussion highlights procedural and constitutional concerns without resolving specific legislative outcomes.
The Senate debated Bill S-218 on June 3, 2025, discussing its implications for the 'notwithstanding' clause and related legislative proposals, with no immediate decision on a motion to adjourn.
The Senate debate on June 3, 2025, focused on Bill S-218, which proposes amendments to the 'notwithstanding' clause in the Charter of Rights and Freedoms. Senators discussed the potential impact of limiting this clause on legislative authority, with some arguing it would restrict federal power and others emphasizing its role in protecting minority rights. The debate also referenced Bill C-21 and other legislative proposals, with mentions of constitutional provisions like section 90. A motion to adjourn the Senate was tabled but not immediately decided.
The Senate debated issues related to child benefits, sterilization consent, and a private insurance merger bill, with discussions on policy implementation and ethical considerations.
The Senate debate focused on several key issues. First, the Hon. David M. Wells raised concerns about the Canada Child Benefit and Canada Child Tax Credit, emphasizing the need for clarity in implementation. The Hon. Scott Tannas responded by highlighting the government's efforts to improve the system. Later, the debate shifted to Bill S-228, which addresses sterilization without consent, with senators discussing its implications for vulnerable populations. A private bill, S-1001, was also debated, involving a merger of insurance companies. Senator Tannas declared a private interest in this bill. Finally, a motion was proposed to refer certain documents to the Ethics Committee for review.
The Senate debate transcript covers discussions on Bill S-1001 (a financial merger), an AI inquiry motion, and procedural motions, with no final legislative decisions recorded.
The Senate debate transcript includes discussions on several bills and motions. A senator introduced Bill S-1001, which proposes a merger between Gore Mutual and Beneva, with the goal of creating a stronger financial institution. The senator emphasized the importance of the merger for the financial sector and requested support. Another segment discusses the need for an inquiry into artificial intelligence development, highlighting concerns about risks like fake news and algorithmic bias. The debate also mentions the importance of balancing innovation with regulation. A motion to adjourn the Senate was proposed but not immediately decided. The text includes references to private bills and procedural motions, but no final legislative outcomes are recorded.
On June 12, 2025, the Senate debated agricultural policy and supply management reforms, with no bills passed and a motion to adjourn the session.
On June 12, 2025, the Senate debated several bills and motions. Key topics included: 1. Bill C-202 (Supply Management): Senators discussed its impact on small farms, with emphasis on protecting Canadian producers from U.S. market volatility. The Bloc Québécois and Quebec's National Assembly supported the bill, citing its role in maintaining price stability for dairy and poultry sectors. A motion to adjourn the Senate was passed, with the next sitting scheduled for June 17, 2025. 2. Bill C-282 (Food Security): Debate focused on soil degradation and the need for sustainable agricultural practices. Senators referenced a Food and Agriculture Organization report highlighting the urgency of addressing soil health. 3. Procedural Actions: The Senate adjourned for the day, with no votes recorded. No bills were passed in the Senate on this date. The debates emphasized agricultural policy, supply management, and environmental sustainability, with no legal changes enacted during this session.
The Senate debated and adopted a motion to protect Canada's supply management system for dairy, poultry, and eggs, while discussing separate proposals to strengthen soil health and agricultural trade policies.
The Senate debated several bills on June 12, 2025, focusing on agricultural policy. Key topics included: 1. Bill C-202 (soil health): A motion to amend the Agriculture Act to establish a national soil health strategy. The debate emphasized the importance of soil for food security, climate resilience, and long-term agricultural planning. Supporters highlighted the need for government-led initiatives and collaboration with stakeholders. 2. Bill C-202 (supply management): A motion to protect Canada's supply management system for dairy, poultry, and eggs. The discussion centered on maintaining food security, supporting small-scale farmers, and countering large corporate imports. Quebec's support for the system was noted, with references to international trade agreements like CUSMA. 3. Bill C-282: A separate motion to amend the Department of Foreign Affairs, Trade and Development Act to strengthen supply management. The debate included arguments about balancing domestic interests with global trade obligations. The Senate adopted the motion for Bill C-202 (supply management) unanimously, reflecting cross-party support for protecting Canada's agricultural system.
The Senate completed its committee consideration of Bill S-201 on October 23, 2025, as part of the legislative process to establish a national framework for sickle cell disease, with the bill now advancing to third reading.
This record documents the Senate's consideration of Bill S-201 in committee, which concluded on October 23, 2025. The bill, titled 'An Act respecting a national framework on sickle cell disease,' is currently at second reading in the House of Commons. During the Senate committee stage, the bill underwent detailed examination as part of the legislative process. The committee sessions occurred on October 1, 2, 8, and 22, 2025, with the final session on October 23. This stage is procedural and does not itself change the law. The bill will next proceed to third reading in the Senate on November 18, 2025, before moving to the House of Commons for further stages.
The Senate completed the first committee report for Bill S-201 on October 23, 2025, with no amendments, but other unrelated topics dominated the session's discussion.
On October 23, 2025, the Senate held a sitting during the consideration-in-committee stage for Bill S-201 (national framework on sickle cell disease). The official record shows the first report from the Social Affairs, Science and Technology Committee was presented without amendment. This procedural step marked the completion of the committee's initial review of the bill. Other discussions in the same sitting focused on unrelated topics such as the UBC Women in House Program, Veterans Affairs initiatives, and debates on separate bills (S-206 and S-216). No further legislative action on Bill S-201 is indicated in this record.
The Senate completed its third reading of Bill S-201 on November 18, 2025, advancing it to the next legislative stage, though the bill remains at second reading in the House of Commons.
This record documents the completion of the Senate's third reading of Bill S-201 on November 18, 2025. The bill, which proposes a national framework for sickle cell disease, had previously passed its first reading in the Senate on June 3, 2025. The third reading stage involved procedural voting to advance the bill to the next stage in the legislative process. The bill is currently at second reading in the House of Commons. No legal changes were enacted through this stage alone. Similar bills (S-280, C-221, C-605) from previous parliaments are noted but have different statuses and are not directly related to this specific stage.
The Senate debated healthcare-related bills, authorized fisheries studies, initiated a tourism inquiry, and paid tribute to Senator Massicotte.
The Senate debated several bills and motions, including Bill S-204 (Heart Failure Awareness Act), Bill S-225 (National Thanadelthur Day Act), and Bill S-217 (National Framework for Diabetes Act). The discussion emphasized the importance of collaborative healthcare policy frameworks, with references to the National Framework for Diabetes Act as a model for addressing chronic conditions. The Senate also authorized the Standing Senate Committee on Fisheries and Oceans to study Pacific Coast fisheries and initiated an inquiry into tourism's role in nation-building. A tribute was paid to Senator Paul Massicotte for his contributions to Canadian public life.
Bill S-201 completed its first reading in the House of Commons on December 11, 2025, and is now proceeding to second reading.
This record documents the procedural step of the first reading of Bill S-201 in the House of Commons. On December 11, 2025, the bill was introduced and its title was read, marking the initial stage in the legislative process. No debate or voting occurred during this stage. The bill is now at second reading in the House of Commons, scheduled for April 17, 2026.
The local model returned a partial structured draft. This summary requires human review before publication.
The local model returned a partial structured draft. This summary requires human review before publication.
Bill S-201 is undergoing second reading in the House of Commons as of April 17, 2026, with procedural steps and speeches recorded but no legal changes enacted yet.
Bill S-201, which proposes a national framework for sickle cell disease, is currently at the second reading stage in the House of Commons. The latest recorded activity was a debate on April 17, 2026, during Sitting 105. This stage follows the bill's first reading on May 28, 2025, and its second reading on June 3, 2025. Key speeches during the second reading included contributions from Liberal sponsor Michael Coteau and Conservative respondents Carol Anstey and Mario Simard. The bill will proceed to committee consideration and potentially third reading in the House before moving to the Senate.
Leslie criticized the government for neglecting economic, environmental, and middle-class concerns, citing the carbon tax and Kinder Morgan pipeline as key examples of policy failure.
The speaker, Leslie, criticized the government for failing to address key issues such as the carbon tax, the Kinder Morgan pipeline, economic challenges, job creation, and concerns for the middle class. The discussion focused on the government's perceived inaction on these matters, with repeated emphasis on the carbon tax and pipeline projects as examples of policy shortcomings. The session concluded with the House adjourned.
The parliamentary discussion highlighted debates over Bill C-22's digital law enforcement provisions and support for Bill S-201's health care framework, with no recorded votes or outcomes.
The discussion focused on legislative proposals related to digital law enforcement and health care. Bill C-22, a law and order bill for a digital country, was mentioned as a third iteration of similar legislation. Critics argued it lacks sufficient oversight mechanisms and privacy protections. The National Framework on Sickle Cell Disease Act (Bill S-201) received support for its potential to improve care and research for sickle cell disease patients. No votes or final outcomes were recorded in the provided text.
The local model returned a partial structured draft. This summary requires human review before publication.
The local model returned a partial structured draft. This summary requires human review before publication.
The parliamentary discussion highlighted debates over Bill C-22's digital law enforcement provisions and support for Bill S-201's health care framework, with no recorded votes or outcomes.
The discussion focused on legislative proposals related to digital law enforcement and health care. Bill C-22, a law and order bill for a digital country, was mentioned as a third iteration of similar legislation. Critics argued it lacks sufficient oversight mechanisms and privacy protections. The National Framework on Sickle Cell Disease Act (Bill S-201) received support for its potential to improve care and research for sickle cell disease patients. No votes or final outcomes were recorded in the provided text.
This House of Commons sitting on June 16, 2026, included the second reading and committee referral of Bill S-201, alongside debates and procedural matters on other legislation.
This artifact is a record of a sitting of the House of Commons on June 16, 2026. It details various procedural actions, including the introduction of bills, committee reports, and debates on several pieces of legislation. Notably, it records the second reading and referral to committee of Bill S-201, An Act respecting a national framework on sickle cell disease. The record also includes extensive debate and divisions related to other government bills and points of order concerning parliamentary procedure.
Bill S-201 is currently undergoing consideration by a House of Commons committee, with no specific activity yet recorded at this stage.
The House of Commons is currently considering Bill S-201, An Act respecting a national framework on sickle cell disease, in committee. This stage involves detailed examination of the bill by a committee of Members of Parliament. The record indicates that no specific committee activity or debate has occurred yet at this stage. The bill was previously read for the second time on Tuesday, June 16, 2026, which led to its referral to this committee.
The House of Commons Report stage for Bill S-201, concerning a national framework on sickle cell disease, has not yet occurred, with the latest procedural step being its second reading and referral to committee on June 16, 2026.
This artifact describes the legislative progress of Bill S-201, an Act respecting a national framework on sickle cell disease. The House of Commons Report stage for this bill has not yet been reached. The latest recorded activity was the bill's second reading and referral to committee on Tuesday, June 16, 2026. The artifact also lists the bill's progress through First Reading, Second Reading, consideration in committee, and Third Reading dates in both the House of Commons and the Senate, along with dates of major speeches given by sponsors and respondents.
Bill S-201, concerning a national framework for sickle cell disease, has reached the Third reading stage in the House of Commons, with previous stages including committee consideration and agreement at second reading.
This artifact describes the procedural status of Bill S-201, An Act respecting a national framework on sickle cell disease, in the House of Commons. The bill has reached the stage of Third reading, but this specific procedural step has not yet occurred. The summary also lists the dates of previous procedural stages, including first reading, second reading, and committee consideration, as well as a record of when the bill was agreed to at second reading and referred to committee. Information about similar bills from previous Parliaments is also provided.
Debate and sitting links point to official parliamentary sources when LEGISinfo publishes them. Any plain-language discussion summaries should be generated from those official texts and reviewed before public display.
Vote Summary
This bill is still active. We only show vote counts after the legislature publishes a recorded division.
No published representative vote breakdown
This bill is still moving through the process. When a recorded division is published, representative positions can be listed here.
Official sources
Status, sponsor, votes, and timeline on this page are drawn from these official legislative sources and public records. Each summary above is attributed to its own source.
How this data is sourced